Quant Venture Fund

Active

Updated: Apr 1, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Nov 1, 2022	Zenas BioPharma	$120.0M Series B	James Boylan	venBio, Vivo Capital, Agent Capital, Fairmount, Patrick Enright, Perceptive Advisors, Pivotal bioVenture Partners, Rock Springs Capital, Superstring Capital, Tellus BioVentures, Wellington Management, Xencor

Total Raised

N/A

Valuation

N/A